BNP/CALL/MERCK & CO./120/0.1/20.12.24 Share Price

Warrant

DE000PE89AF7

Market Closed - Deutsche Boerse AG 01:20:31 05/07/2024 am IST
1.05 EUR -3.67% Intraday chart for BNP/CALL/MERCK & CO./120/0.1/20.12.24
Current month-11.76%
1 month-22.22%
Date Price Change
04/24/04 1.05 -3.67%
03/24/03 1.09 -12.80%
02/24/02 1.25 -3.85%
01/24/01 1.3 +9.24%
28/24/28 1.19 -16.20%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 01:20 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE89AF
ISINDE000PE89AF7
Date issued 16/02/2023
Strike 120 $
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 0.9
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.8
Lowest since issue 0.26
Delta0.67x
Omega 7.374
Premium4.5x
Gearing10.93x
Moneyness 1.049
Difference Strike -5.85 $
Difference Strike %-4.88%
Spread 0.03
Spread %2.78%
Intrinsic value 0.5411

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus